Do airway inflammation and airway responsiveness markers at the start of apprenticeship predict their evolution during initial training? A longitudinal study among apprentice bakers, pastry makers and hairdressers

BMC Pulmonary Medicine Research article - Open Access - Open Peer Review
Valérie Demange, Denis Zmirou-NavierAbraham Bohadana and Pascal Wild

Abstract

Background

The natural history of airway inflammation and symptoms in occupations at risk of asthma is still not fully understood. We aimed to study the evolution during apprenticeship of inflammation markers, bronchial hyperresponsiveness (BHR) and symptoms in at-risk subgroups as defined from measurements of markers made shortly after the start of training.

Methods

Respiratory symptoms, FEV1 and airway resistance post-bronchial challenge (MBC) test results, fractional exhaled nitric oxide (FeNO) measurements, and eosinophils in nasal lavage fluid were investigated in apprentice bakers, pastry-makers and hairdressers. Four visits were conducted: at the start of the training and every six months thereafter. Four baseline risk groups were defined, based on, (i) a high level of FeNO (NO), (ii) eosinophils > 1% (Eosino), (iii) a ≥ 15% decrease in FEV1 during the MBC test (HR), and (iv) a ≥ 50% increase in the resistance (Resist). The statistical analysis relied on mixed models.

Results

At baseline, the inflammation markers were related to the MBC markers. There was no evidence to suggest that the baseline risk groups predict a differential evolution of the airway inflammation and bronchial responsiveness markers, or the asthma-like symptoms considered. The baseline risk groups defined from MBC test predicted the levels of MBC markers. Similarly, the baseline risk groups based on eosinophilic inflammation predicted the levels of markers for eosinophilia. These results were similar in the three training tracks, with the exception of the FeNO levels which were not different according to the Eosino risk group. Twelve possible new asthma cases were identified, only the HR risk group predicted their occurrence.

Conclusions

Among this young population, at-risk groups based on initial high levels of inflammation markers did not experience any worsening during the follow-up. However, initial BHR predicted consistently high levels of all markers considered and occurrence of possible asthma.

Download PDF

(You must be logged in to add and reply comments)

Interasma on Twitter

Interasma Top story: WORLD ALLERGY CONGRESS | WAC2019 - WORLD ALLERGY CONGRESS https://t.co/KpUHk6kq9r, see more https://t.co/CpGiFuOOYd
4hreplyretweetfavorite
Interasma RT @worldallergy: Top story: Conjunctivitis Seen in Patients on Dupixent | Medpage Today https://t.co/WzoMs3nmNr, see more https://t.co/yY2
10hreplyretweetfavorite
Interasma RT @WAOJM: Beirut, Lebanon - 4-6 April 2019 Visit the WISC 2019 Website for details! https://t.co/Hz6qBiFuIm
10hreplyretweetfavorite
Interasma RT @AllergyEaaci: How to discontinue omalizumab in chronic spontaneous urticaria? Download Article Here: https://t.co/CnLrzLyZ4J #allergy #…
10hreplyretweetfavorite

Editor: Juan C. Ivancevich, MD

Copyright © Interasma 2003-2017  •  Terms of Use  •  Privacy Policy  •  Contact Us  •  Sitemap

Powered by FREI SA

InterAsma